Skip to main content
. 2010 Apr 1;2(1):37–43. doi: 10.5114/jcb.2010.13721

Table 3.

Number of patients with OARs D2cc total dose exceeding the recommended tolerance

Bladder Rectum Sigmoid
Number of patients (n = 10) 3/10 7/10 5/10

Data presented as number of patients with OARs D2cc total dose exceeding the (GYN) GEC-ESTRO Working Group [9] recommended tolerance (Bladder > 90GyEQD2, Rectum and Sigmoid > 70-75GyEQD2)